We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ELEV market cap is 35.94M. The company's latest EPS is USD -0.7731 and P/E is -0.72.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.92M | -7.95M | -9.87M | -10.96M | -13.23M |
| Net Income | -10.64M | -7.9M | -10.71M | -10.46M | -12.88M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -32.05M | -94.55M | -45.45M |
| Net Income | -32.04M | -95.08M | -45.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 99.98M | 89.09M | 108.96M | 114.6M | 106.3M |
| Total Liabilities | 37.56M | 34.28M | 33.14M | 33.68M | 36.95M |
| Total Equity | 62.42M | 54.81M | 75.82M | 80.92M | 69.36M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 149.49M | 94.16M | 89.09M |
| Total Liabilities | 8.8M | 45.13M | 34.28M |
| Total Equity | 140.7M | 49.03M | 54.81M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -44M | -56.18M | -9.58M | -17.78M | -26.16M |
| Investing | 4.98M | 11.54M | 20.7M | -16.96M | -19.83M |
| Financing | 47.98M | 47.98M | 30.25M | 44.93M | 44.94M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.17M | -85.48M | -56.18M |
| Investing | N/A | -44.4M | 11.54M |
| Financing | 97.05M | 29.51M | 47.98M |
| Market Cap | 35.94M |
| Price to Earnings Ratio | -0.72 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.67 |
| Price to Book Ratio | 0.6 |
| Dividend Yield | - |
| Shares Outstanding | 59.12M |
| Average Volume (1 week) | 754.04k |
| Average Volume (1 Month) | 763.94k |
| 52 Week Change | 19.22% |
| 52 Week High | 5.8299 |
| 52 Week Low | 0.4401 |
| Spread (Intraday) | 0.03 (4.39%) |
| Company Name | Elevation Oncology Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.elevationoncology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
